InDex Pharmaceuticals Holding AB (publ) Receivables

InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) currently reports a receivables of $0 as of March 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore InDex Pharmaceuticals Holding AB (publ)'s receivables history and peer comparisons.

InDex Pharmaceuticals Holding AB (publ)'s receivables changed from $0 to $0 (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

InDex Pharmaceuticals Holding AB (publ) reported $0 in receivables as of March 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for InDex Pharmaceuticals Holding AB (publ), and consider following INDEX.ST for alerts when major investors trade the stock.

InDex Pharmaceuticals Holding AB (publ) is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INDEX.ST with unrelated industries.